Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis

✍ Scribed by Gavin Giovannoni; Stuart Cook; Kottil Rammohan; Peter Rieckmann; Per Soelberg Sørensen; Patrick Vermersch; Anthony Hamlett; Vissia Viglietta; Steven Greenberg

• Book ID: 114409735
• Publisher: The Lancet
• Year: 2011
• Tongue: English
• Weight: 246 KB
• Volume: 10
• Category: Article
• ISSN: 1474-4465
• DOI: 10.1016/s1474-4422(11)70023-0